Industry / United Kingdom
Suicide Assessment For Drugs Considered
February 2008 | Industry NewsIn what could be a damaging move for sales of certain products, although ultimately positive for some antidepressants, ,the UK is considering giving every new drug licensed in the country a 'suicide rating'. This will likely be achieved through adding comprehensive suicide assessments into clinical trials.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
